This site is intended for U.S. audiences only.

β-thalassemia

MDS

β-thalassemia

β-thal

MDS

MDS

β-thalassemia

How do I receive REBLOZYL?

REBLOZYL will be given to you by a healthcare professional

  • REBLOZYL is given as an injection under the skin (subcutaneous) with a needle. Needles used for injections under the skin are smaller than those used for injections into muscle (intramuscular)
  • Your healthcare provider will prescribe REBLOZYL in a dose that is right for you. Your healthcare provider will calculate the exact dose of REBLOZYL you will need based on your weight, and you will receive it once every 3 weeks in a doctor’s office
  • Your doctor or another healthcare provider will check your hemoglobin levels each time before you receive REBLOZYL, and may increase or decrease your dosing amount or adjust your dosing schedule based on the results
  • If your scheduled REBLOZYL dose is delayed or missed, your healthcare provider will give your dose of REBLOZYL as soon as possible and continue your treatment as prescribed with at least 3 weeks between doses

Where will REBLOZYL be injected?

  • REBLOZYL is given as an injection under your skin (subcutaneous) by your healthcare provider
    • The injection may be given in the upper arm, thigh, or abdomen

Receiving Reblozyl (MDS) | Graphic depicting person with possible injection sites highlighted
Receiving Reblozyl (MDS) | Graphic depicting person with possible injection sites highlighted

How long might I receive treatment with REBLOZYL?

You should receive REBLOZYL as long as your doctor finds it is working for you and you are able to tolerate any potential side effects that may occur

  • Your healthcare provider may adjust your dose or stop treatment depending on how you respond to REBLOZYL
  • Your healthcare provider will decide when you should receive REBLOZYL based on your response, which will include your current symptoms and any reduction in your need for red blood cell transfusions, so be sure to follow his or her instructions
  • Your healthcare provider may consider a dose increase based on how you respond to REBLOZYL
  • Your healthcare provider may also decrease your dose or stop your dose if you experience certain side effects or no reductions in transfusions

What was the dosing experience in the clinical trial?

6 out of every 10 (67%) patients
received REBLOZYL for 6 months or longer

Half of patients (49%)
received REBLOZYL for greater than 1 year

Reblozyl (MDS) | Graphic with suggestion to speak to your doctor for more information

Talk to your doctor or another healthcare professional about what this means for you

Next

Resources and support

What is REBLOZYL® (luspatercept-aamt)?

REBLOZYL is a prescription medicine used to treat anemia (low red blood cells) in adults with:

  • beta thalassemia who need regular red blood cell (RBC) transfusions.
  • myelodysplastic syndromes with ring sideroblasts (MDS-RS) or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) who need regular RBC transfusions and have not responded well to or cannot receive an erythropoiesis stimulating agent (ESA).

REBLOZYL is a prescription medicine used to treat anemia (low red blood cells) in adults with myelodysplastic syndromes with ring sideroblasts (MDS-RS) or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) who need regular RBC transfusions and have not responded well to or cannot receive an erythropoiesis stimulating agent (ESA).

REBLOZYL is a prescription medicine used to treat anemia (low red blood cells) in adults with beta thalassemia who need regular red blood cell (RBC) transfusions.

REBLOZYL is not for use as a substitute for RBC transfusions in people who need immediate treatment for anemia. It is not known if REBLOZYL is safe or effective in children.

Before receiving REBLOZYL, tell your healthcare provider about all of your medical conditions, including if you:

  • have or have had blood clots
  • have or have had high blood pressure (hypertension)
  • take hormone replacement therapy or birth control pills (oral contraceptives)
  • have had your spleen removed (splenectomy)
  • smoke
  • are pregnant or plan to become pregnant. REBLOZYL may harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with REBLOZYL.

    • Females who are able to become pregnant:

    • Your healthcare provider should do a pregnancy test before you start treatment with REBLOZYL.
    • You should use effective birth control (contraception) during treatment with REBLOZYL and for at least 3 months after the last dose.
  • are breastfeeding or plan to breastfeed. It is not known if REBLOZYL passes into your breast milk.
    • Do not breastfeed during treatment with REBLOZYL and for 3 months after the last dose. Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements

What are the possible side effects of REBLOZYL?

REBLOZYL may cause serious side effects, including:

  • Blood clots. Blood clots in the arteries, veins, brain, and lungs have happened in people with beta thalassemia during treatment with REBLOZYL. The risk of blood clots may be higher in people who have had their spleen removed or who take hormone replacement therapy or birth control (oral contraceptives). Call your healthcare provider or get medical help right away if you have any of these symptoms:
    • chest pain
    • trouble breathing or shortness of breath
    • pain in your leg, with or without swelling
    • a cold or pale arm or leg
    • sudden numbness or weakness that are both short-term or continue to happen over a long period of time, especially on one side of the body
    • severe headache or confusion
    • sudden problems with vision, speech, or balance (such as trouble speaking, difficulty walking, or dizziness)
  • High blood pressure. REBLOZYL may cause an increase in your blood pressure. Your healthcare provider will check your blood pressure before you receive your REBLOZYL dose. Your healthcare provider may prescribe you medicine to treat high blood pressure or increase the dose of medicine you already take to treat high blood pressure, if you develop high blood pressure during treatment with REBLOZYL.

The most common side effects of REBLOZYL include:

    • tiredness
    • muscle or bone pain
    • dizziness
    • diarrhea
    • stomach (abdominal) pain
    • allergic reactions
    • headache
    • joint pain (arthralgia)
    • nausea
    • cough
    • trouble breathing

REBLOZYL may cause fertility problems in females. This could affect your ability to become pregnant. Talk to your healthcare provider if this is a concern for you.

These are not all of the possible side effects of REBLOZYL. Call your doctor for medical advice about side effects. You are encouraged to report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see full Prescribing Information and Patient Information for REBLOZYL.